Mesa Laboratories, Inc. MLAB
NASDAQ · United States · Health Technology
$133.76+4.46 (+3.45%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 2026-08-10 | 2.68 | 2.63 | +2.1% | $60.14M | -1.2% | +8.4%$102.65→$111.23 |
| Q4 2026 | 2026-05-27 | 1.83 | 1.39 | +31.7% | — | — | -2.9%$106.17→$103.10 |
| Q4 2025 | 2025-05-28 | 0.43 | 2.07 | -79.2% | — | — | — |
| Q4 2024 | 2024-06-05 | 1.21 | 1.75 | -30.9% | — | — | — |
| Q3 2024 | 2024-02-05 | 2.62 | 1.70 | +54.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.